CS logo
small CS logo
UChicago Medicine - River East

Chicago, Illinois, United States
Medical center in Chicago, Illinois
355 E Grand Ave, Chicago, IL 60611

About UChicago Medicine - River East


"Located in Chicago’s Streeterville neighborhood, UChicago Medicine River East is a state-of-the-art outpatient center featuring a wide range of care services: Primary care Specialty care for more than 25 specialty areas Cancer screenings Infusion therapy Lab testing services"
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at UChicago Medicine - River East


During the past decade, UChicago Medicine - River East conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "UChicago Medicine - River East" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

Clinical Trials Conditions at UChicago Medicine - River East


According to Clinical.Site data, the most researched conditions in "UChicago Medicine - River East" are "Multiple Myeloma" (2 trials) and "Neoplasms" (1 trials). Many other conditions were trialed in "UChicago Medicine - River East" in a lesser frequency.

Clinical Trials Intervention Types at UChicago Medicine - River East


Most popular intervention types in "UChicago Medicine - River East" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "5-FU" (1 trials), "Bevacizumab" (1 trials), "Capecitabine" (1 trials), "Cetuximab" (1 trials) and "Elranatamab + Nirogacestat" (1 trials). Other intervention names were less common.

Clinical Trials Genders at UChicago Medicine - River East


The vast majority of trials in "UChicago Medicine - River East" are 3 trials for "All" genders.

Clinical Trials Status at UChicago Medicine - River East


Currently, there are NaN active trials in "UChicago Medicine - River East". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in UChicago Medicine - River East, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in UChicago Medicine - River East, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".